Mylan's quarterly revenue jumps 31 percent
March 01, 2017 at 07:58 AM EST
(Reuters) - Generic drugmaker Mylan NV reported a 31.2 percent rise in quarterly revenue, helped by demand for products it gained through the acquisition of Swedish drugmaker Meda last year.
